Fluoxetine Janus dendrimer shows potent anticancer activity against MCF-7 cells
Fluoxetine Janus dendrimers demonstrated significant cytotoxicity against MCF-7 cancer cells, indicating potential for new treatment strategies.
Therapeutic Area
Therapeutic area intelligence for Dendrimer-based therapy with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.